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Antibiotics X-14667A (1) and X-14667B (2) are novel monovalent polyether antibiotics of the spiroketal type isolated from fermented cultures of Streptornyces cinnamonensis subsp. urethanofaciens together with monensin (3), its lower homolog, factor B (4) and 1,3-diphenethylurea (6) . By a combination of microanalysis, mass spectrometry and 13C nmr, antibiotics X-14667A and B have been shown to be natural 2-phenethylurethanes of monensin B and A respectively. Both structures have been confirmed by reacting the appropriate monensin with 2-phenethylisocyanate to yield semi-synthetic compounds that are identical to the natural products.
Antibiotics X-14667A (1) and X-14667B (2) are the latest additions to the more than sixty carboxylic acid ionophores1) known as polyether antibiotics2).
They are closely related to the first polyether antibiotic to be structurally defined3), monensin (3), and a lower homolog of monensin called factor B", or monensin B (4). The first naturally occurring analog of monensin to be reported') was laidlomycin (5) , which was also the first polyether claimed to exhibit antimycoplasmal activity. Laidlomycin differs from monensin B at carbon C-3 where the only methoxyl group present in the monensins is replaced by a propionyloxyl function. In contrast to this, the difference between antibiotic X-14667A and monensin B
(and between X-14667B and monensin) is at the opposite end of the molecule, at C-26, where a primary alcohol is transformed into a 2-phenethylurethane moiety, a function not previously encountered amongst the polyether antibiotics. The availability of the alcohol at C-26 to both microbial and chemical transformation has been demonstrated in the glucosylation of monensin to antibiotic A271O6 using Sodium salt-complexes of antibiotics X-14667A (R= Me) and X-14667B (R=Et). is probably present in Streptomyces sp. AM-2498 which has also been reported"' to produce 1,3-diphenethylurea.
As reported in the accompanying paper'', antibiotics X-14667A and B, like the monensins and laidlomycin, complex alkaline but not alkaline earth cations. This makes them part of the monovalent class2) of polyethers which already accounts for half of the carboxylic ionophores reported so far. As discussed recently in regard to another antibiotic10), if the presence and nature of the spiroketal function is taken into account, the monovalent class of polyethers can be divided into three types:
(1) non-spiroketal (e.g., alborixin11) and X-20612)) (2) spiroketal (the monensins and nigericin13,14)) (3) dispiroketal (salinomycin15) and the noboritomycins16,17)).
This notation will be used in the present and any future communications from this laboratory concerning monovalent polyether antibiotics.
Specifically, this report describes the isolation and characterization of two novel monovalent polyethers of the spiroketal type, antibiotics X-14667A and X-14667B. The confirmation of the structures of these two novel antibiotics was accomplished by their synthesis from monensin and monensin B by reaction with 2-phenethylisocyanate, and this facile transformation suggested the production of other semisynthetic monensin urethanes. The variations of cation specificity and biological activity for a number of these compounds will be the subject of a future report. 138-141°C), the structure (6) of which was established by microanalysis, mass spectrometry (M+, m/z 268) and 13C nmr in CD2Cl2 (see Table 1 ). Pooled fractions 86-121 yielded a further 2 g of antibiotic X-14667A, and fractions 55-85 were concentrated under reduced pressure to 3.5 g of a mixture of 1 and 2 which was resolved on the Waters Prep LC-500TM using hexane -acetone (8: 2) as eluent to give a further 1.2 g of antibiotic X-14667A (1) and 1.8 g of antibiotic X-14667B (2) The 23 grams of crystalline mixture isolated from the original extract (vide supra) was resolved by fractional crystallization into 6.7 g of 1,3-diphenethylurea (6), 6.5 g of monensin B (4) and 350 mg of monensin (3), which were all identified by methods described in the references3,4,8) including microanalysis, TLC, mass spectrometry and 13C nmr.
Characterization of Antibiotics X-14667A and 14667B
Field desorption mass spectrometry of antibiotic X-14667A sodium salt by Dr. CARTER COOK of the University of Illinois yielded a molecular ion that was in agreement with the molecular formula of C44H88NO12Na (826.02), calculated from microanalytical data. Conventional electron impact (EI) mass spectrometry did not yield a molecular ion but several fragment ions were noted, including those at m/z 677, 647, 603, 477, 391, 307, 147 and 91. The coincidence of finding the first six peaks in this list also in the El mass spectrum of monensin B (4), isolated from S. cinnamonensis subsp. urethanofaciens, as well as the literature spectrum of monensin B18), led us to the conclusion that antibiotic X-14667A must be a derivative of this lower monensin homolog, and a comparison of molecular formulae showed that the two molecules differed by C9H9NO. The presence in the fermentation of 1,3-diphenethylurea(6), in addition to monensin B (4), suggested that antibiotic X-14667A (1) is probably the 2-phenethylurethane of monensin B, as this would account for the difference in molecular formulae between 1 and 4.
Further support for this proposal is also to be found in the two mass spectral peaks which distinguish 1 (Fig. 1) .
A comparison of the 13C nmr spectra of the sodium salts of X-14667A (1) and monensin B (4) in CD2Cl2 revealed that there were forty-four carbons in 1, which is nine carbons more than are present in 4. This is in agreement with the molecular formula of C44H68NO12Na derived from microanalytical and mass spectral analysis.
The presence of a 2-phenethylurethane was further supported by comparing the chemical shifts in the 13C nmr spectra of 1 with that of its co-metabolite, diphenethylurea (6) . There were peaks due to nine carbons that were very similar in 1 and 6
and did not appear in the spectrum of monensin B (Table 1 ).
By analogous methods described for characterization of antibiotic X-14667A (1), antibiotic X-14667B was shown by microanalysis, mass spectrometry and 13C nuclear magnetic resonance to be 2, a higher homolog of X-14667A, the 2-phenethylurethane of monensin. The final confirmation of the structures of antibiotics X-14667A and X-14667B as 1 and 2 was accomplished by synthesis from monensin B and A respectively.
Semi-synthetic Preparation of Antibiotic X-14667A
To a stirred solution of the sodium salt of monensin B (2.034 g, 3 mmole) in benzene was added 2-phenethylisocyanate (733 mg, 5 mmole). After reacting for 10 days at room temperature, the reaction mixture was washed in turn with aqueous Na2CO3 and water and then evaporated under reduced pressure to yield the 2-phenethylurethane of monensin B (2.11 g) which was identical by mp, [a]D, microanalysis, U V and IR spectra, NMR and mass spectrometry to the sodium salt of antibiotic X-14667A (1).
The analogous reaction using the sodium salt of monensin yielded the sodium salt of antibiotic X-14667B (2). 
